Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants

By sjmartinez • February 11, 2023

Junker D, Becker M, Wagner TR, Kaiser PD, Maier S, Grimm TM, Griesbaum J, Marsall P, Gruber J, Traenkle B, Heinzel C, Pinilla YT, Held J, Fendel R, Kreidenweiss A, Nelde A, Maringer Y, Schroeder S, Walz JS, Althaus K, Uzun G, Mikus M, Bakchoul T, Schenke-Layland K, Bunk S, Haeberle H, Göpel S, Bitzer M, Renk H, Remppis J, Engel C, Franz AR, Harries M, Kessel B, Lange B, Strengert M, Krause G, Zeck A, Rothbauer U, Dulovic A, Schneiderhan-Marra N. Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants. Clin Infect Dis. 2023 Feb 8;76(3):e240-e249. doi: 10.1093/cid/ciac498. PMID: 35717657; PMCID: PMC9384292.

Tags: antibody binding, Cardiology/Epi, multiplex, Omicron, Publications, SARS-CoV-2, variants of concern

Follistatin Mitigates Atherosclerosis Through Activation of Arginine Metabolism and Adipose Browning

Dirakvand G, Pervin S, Villa B, Le C, Yohanna K, Grijalva V, Chattopadhyay A, Sinha SK, Reddy ST, Singh R. Follistatin Mitigates Atherosclerosis Through Activation[...]

Tenecteplase vs Alteplase and Time to Treatment for Acute Ischemic Stroke

Warach SJ, Weber JM, Alhanti B, Messé SR, Schwamm LH, Fonarow GC, Sheth KN, Smith EE, Mullen MT, Silva GS, Mac Grory B, Xian Y,[...]

Outcomes of Early Sodium-Glucose Cotransporter Two Inhibitor Use in Takotsubo Syndrome: Insights From a Multicenter Real-World Cohort Study

Taha A, Mondal A, Sandhyavenu H, Atti L, Alhajji M, Thangjui S, Shaik BF, Thyagaturu H, Caccamo M, Fonarow GC, Balla S. Outcomes of Early[...]